← Back to headlines
AstraZeneca Shares Rise on Positive Lung Drug Trial Results
AstraZeneca's stock saw a boost after its new lung drug successfully met its objectives in late-stage clinical trials.
27 Mar, 15:34 — 27 Mar, 15:34
Sources
Showing 1 of 1 sources
